Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen.
Lea, C K
Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen. [electronic resource] - The Journal of endocrinology Feb 1998 - 331-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-0795
10.1677/joe.0.1560331 doi
Androstenedione--blood
Animals
Bone Remodeling--drug effects
Delayed-Action Preparations
Disease Models, Animal
Dose-Response Relationship, Drug
Estradiol--blood
Female
Humans
Osteoporosis, Postmenopausal--drug therapy
Ovariectomy
Rats
Rats, Sprague-Dawley
Testosterone--blood
Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen. [electronic resource] - The Journal of endocrinology Feb 1998 - 331-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0022-0795
10.1677/joe.0.1560331 doi
Androstenedione--blood
Animals
Bone Remodeling--drug effects
Delayed-Action Preparations
Disease Models, Animal
Dose-Response Relationship, Drug
Estradiol--blood
Female
Humans
Osteoporosis, Postmenopausal--drug therapy
Ovariectomy
Rats
Rats, Sprague-Dawley
Testosterone--blood